The Immune System
Overview: Recognition and Response
Pathogens are agents that cause disease and infect a wide range of animals, including humans.
The immune system enables animals to avoid or limit many infections.
All animals possess innate immunity, a defense active immediately upon infection.
Vertebrates also have adaptive immunity.
Innate vs. Adaptive Immunity
Innate Immunity:
Includes barrier defenses.
Involves receptor proteins that bind to molecules or structures common to viruses, bacteria, or other microbes.
Binding activates internal defensive responses to a broad range of pathogens.
Adaptive Immunity:
Develops after exposure to agents like microbes, toxins, or other foreign substances.
Involves a very specific response to pathogens.
Concept 35.1: Innate Immunity
Innate immunity is found in all animals and plants.
In vertebrates, it's an immediate response to infections and the foundation of adaptive immunity.
Innate Immunity of Invertebrates
Insects use their exoskeleton as a physical barrier against infection.
Lysozyme in the digestive system breaks down bacterial cell walls.
Immune cells recognize pathogens by binding to specific molecules.
Each recognition protein recognizes a broad class of pathogens.
Hemocytes circulate within hemolymph and carry out phagocytosis (ingestion and breakdown of foreign substances).
Hemocytes release antimicrobial peptides that disrupt the plasma membranes of fungi and bacteria.
Innate Immunity of Vertebrates
Mammalian immune system is the best understood among vertebrates.
Innate defenses include barrier defenses, phagocytosis, and antimicrobial peptides.
Additional defenses unique to vertebrates: natural killer cells, interferons, and the inflammatory response.
Barrier Defenses
Skin and mucous membranes of respiratory, urinary, and reproductive tracts.
Mucus traps and allows removal of microbes.
Body fluids like saliva, mucus, and tears are hostile to microbes.
Low pH of skin and digestive system prevents bacterial growth.
Cellular Innate Defenses
Pathogens entering the mammalian body are subject to phagocytosis.
Phagocytic cells recognize pathogens by Toll-like receptors (TLRs).
Each mammalian TLR binds to fragments of molecules characteristic of a set of pathogens.
Types of Phagocytic Cells:
Neutrophils: circulate in blood and are attracted by signals from infected tissues.
Macrophages: found throughout the body.
Additional Cell Types:
Dendritic cells: stimulate development of adaptive immunity in cells contacting the environment (e.g., skin).
Eosinophils: discharge destructive enzymes.
Cellular innate defenses involve natural killer cells that detect abnormal cells and release chemicals leading to cell death.
Antimicrobial Peptides and Proteins
Pathogen recognition triggers release of peptides and proteins that attack pathogens or impede reproduction.
Interferons provide innate defense by interfering with viruses and activating macrophages.
The complement system consists of about 30 proteins activated by substances on microbe surfaces, leading to lysis of invading cells.
Inflammatory Response
Brought about by molecules released upon injury or infection, leading to pain and swelling.
Activated macrophages and neutrophils release cytokines that modulate the immune response and promote blood flow.
Mast cells release histamine, causing blood vessels to dilate and become more permeable.
Enhanced blood flow delivers antimicrobial peptides, resulting in pus accumulation (white blood cells, dead pathogens, and cell debris).
Inflammation can be local or systemic.
Fever is a systemic inflammatory response triggered by substances released by macrophages.
Septic shock is a life-threatening condition due to an overwhelming inflammatory response.
Chronic inflammation can threaten health.
Evasion of Innate Immunity by Pathogens
Adaptations have evolved in some pathogens to avoid destruction by phagocytic cells.
The outer capsule of some bacteria interferes with molecular recognition.
Tuberculosis (TB) resists breakdown within lysosomes after being engulfed.
Concept 35.2: Adaptive Immunity
Adaptive response relies on two types of lymphocytes (white blood cells):
T cells mature in the thymus.
B cells mature in bone marrow.
Antigen Recognition
Antigens are substances that elicit a response from B or T cells.
Recognition occurs when a B or T cell binds to an antigen via an antigen receptor.
The immune system produces millions of different antigen receptors, but receptors on a single B or T cell are identical.
The small accessible part of an antigen that binds to a receptor is called an epitope.
Antigen Recognition by B Cells and Antibodies
Each B cell antigen receptor is a Y-shaped molecule with two identical heavy chains and two identical light chains.
Constant (C) regions vary little, while variable (V) regions differ greatly among B cells.
V regions of heavy and light chains form an antigen-binding site.
Binding of a B cell antigen receptor to an antigen is an early step in B cell activation.
This gives rise to cells that secrete a soluble form of the protein called an antibody or immunoglobulin (Ig).
Secreted antibodies are similar to B cell receptors but are not membrane-bound and defend against pathogens.
Antigen Recognition by T Cells
Each T cell receptor consists of two different polypeptide chains (α and β).
The tips of the chain form a variable (V) region; the rest is a constant (C) region.
The V regions of the α and β chains together form an antigen-binding site.
T cells bind only to antigen fragments displayed on a host cell.
MHC (major histocompatibility complex) molecules are host proteins that display antigen fragments on the cell surface.
In infected cells, antigens are cleaved into smaller peptides by enzymes.
MHC molecules bind and transport the antigen fragments to the cell surface (antigen presentation).
A T cell can then bind both the antigen fragment and the MHC molecule, necessary for the adaptive immune response.
B Cell and T Cell Development
Four major characteristics:
Diversity of lymphocytes and receptors.
Self-tolerance; lack of reactivity against an animal’s own molecules.
Proliferation of B and T cells after activation.
Immunological memory.
Generation of B Cell and T Cell Diversity
Combining variable elements assembles millions of different receptors.
Capacity to generate diversity is built into the structure of Ig genes.
Many different chains can be produced from the same gene by rearrangement of the DNA.
Rearranged DNA is transcribed and translated, and the antigen receptor is formed.
Example: A receptor light-chain gene contains a variable (V) segment, a joining (J) segment, and a constant (C) segment.
The gene contains one C segment, 40 different V segments, and 5 different J segments. These can be combined in 200 different ways.
The number of heavy-chain combinations is even greater.
Origin of Self-Tolerance
Antigen receptors are generated by random rearrangement of DNA.
As lymphocytes mature in bone marrow or the thymus, they are tested for self-reactivity.
Some B and T cells with receptors specific for the body’s own molecules are destroyed by apoptosis (programmed cell death), and the remainder are rendered nonfunctional.
Proliferation of B Cells and T Cells
Only a tiny fraction of antigen receptors are specific for a given epitope.
In the lymph nodes, an antigen is exposed to a steady stream of lymphocytes until a match is made.
Binding of a mature lymphocyte to an antigen initiates events that activate the lymphocyte.
Once activated, a B or T cell undergoes multiple cell divisions to produce a clone of identical cells (clonal selection).
Some cells become short-lived activated effector cells that act immediately against the antigen.
For B cells, the effector forms are plasma cells, which secrete antibodies.
Long-lived memory cells give rise to effector cells if the same antigen is encountered again.
Immunological Memory
Responsible for long-term protection against diseases due to prior infection.
The first exposure to a specific antigen represents the primary immune response.
During this time, selected B and T cells give rise to their effector forms.
In the secondary immune response, memory cells facilitate a faster, stronger, and longer response.
Immunological memory can span many decades.
Concept 35.3: Adaptive Immunity Defends Against Infection
B and T lymphocytes produce a humoral immune response and a cell-mediated immune response.
In the humoral immune response, antibodies help neutralize or eliminate toxins and pathogens in the blood and lymph.
In the cell-mediated immune response, specialized T cells destroy infected host cells.
Helper T Cells: Activating Adaptive Immunity
A type of T cell called a helper T cell triggers both the humoral and cell-mediated immune responses.
A foreign molecule must be bound by the antigen receptor of the helper T cell.
An antigen must be displayed on the surface of an antigen-presenting cell.
Antigen-presenting cells have class I and class II MHC molecules on their surfaces.
Antigen-presenting cells are recognized based on their class II MHC molecules.
Antigen receptors on the surface of helper T cells bind to the antigen and the class II MHC molecule.
Signals are then exchanged between the two cells.
The helper T cell is activated, proliferates, and forms a clone of helper T cells, which then activate the appropriate B cells.
B Cells and Antibodies: A Response to Extracellular Pathogens
The humoral response is characterized by secretion of antibodies by clonally selected B cells.
Activation of B cells involves helper T cells and proteins on the surface of pathogens.
A single activated B cell gives rise to thousands of identical plasma cells.
Antibodies do not kill pathogens; instead, they mark pathogens for destruction.
In neutralization, antibodies bind to viral surface proteins, preventing infection of a host cell.
Antibodies may also bind to toxins in body fluids and prevent them from entering body cells.
Antigen-antibody complexes may bind to a complement protein, leading to formation of a pore in the membrane of the foreign cell and its lysis.
B cells can express five different forms (or classes) of immunoglobulin (Ig) with similar antigen-binding specificity but different heavy-chain C regions.
One type, the B cell antigen receptor, is membrane bound.
The others are soluble and include those found in blood, tears, saliva, and breast milk.
Cytotoxic T Cells: A Response to Infected Host Cells
Cytotoxic T cells are the effector cells in the cell-mediated immune response.
Cytotoxic T cells recognize fragments of foreign proteins produced by infected cells and possess an accessory protein that binds to class I MHC molecules.
The activated cytotoxic T cell secretes proteins that disrupt the membranes of target cells and trigger apoptosis.
Summary of Humoral and Cell-Mediated Immune Responses
Both the humoral and cell-mediated responses can include primary and secondary immune responses.
Memory cells enable the secondary response.
Active and Passive Immunity
Active immunity occurs naturally when a pathogen infects the body.
Passive immunity provides immediate, short-term protection.
It is conferred naturally when antibodies cross the placenta from mother to fetus or pass from mother to infant in breast milk.
Active immunity is induced when antigens are introduced into the body in vaccines.
In this process of immunization, inactivated bacterial toxins or weakened or killed pathogens are introduced.
Passive immunity can be conferred artificially by injecting antibodies into a nonimmune person.
Antibodies as Tools
Polyclonal antibodies, produced following exposure to an antigen, are products of many different clones of plasma cells, each specific for a different epitope.
Monoclonal antibodies are prepared from a single clone of B cells grown in culture.
Monoclonal antibodies have provided the basis for many recent advances in medical diagnosis and treatment.
Immune Rejection
Cells transferred from one person to another can be destroyed (rejected) by the recipient’s immune defenses.
To minimize rejection, physicians use donor tissue that closely matches the MHC molecules of the recipient.
Recipients also take medicines that suppress their immune responses.
Disruptions in Immune System Function
Adaptive immunity protects against many pathogens but isn't fail-safe.
Allergies
Allergies are exaggerated (hypersensitive) responses to antigens called allergens.
In localized allergies like hay fever, plasma cells secrete antibodies specific for antigens on the surface of pollen grains.
This triggers immune cells in connective tissue to release histamine and other inflammatory chemicals.
Antihistamines block receptors for histamine and diminish allergy symptoms.
An acute allergic response can lead to anaphylactic shock, a life-threatening reaction.
Substances that can trigger anaphylactic shock include bee venom, penicillin, peanuts, and shellfish.
People with these hypersensitivities often carry epinephrine to counteract the allergic response.
Autoimmune Diseases
In individuals with autoimmune diseases, the immune system targets certain molecules of the body.
Autoimmune diseases include systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, and multiple sclerosis.
Genes, heredity, and environment all influence susceptibility to autoimmune disorders.
Immune System Avoidance
Mechanisms to thwart immune responses have evolved in pathogens.
A pathogen may alter how it appears to the immune system by changing the epitopes it expresses (antigenic variation).
This mechanism is seen in the parasite that causes sleeping sickness and in the influenza virus.
Some viruses avoid an immune response by infecting cells and then entering an inactive state called latency.
The virus (such as herpes simplex) remains latent until a stimulus reactivates it.
Stimuli include stress, fever, or menstruation.
Acquired immunodeficiency syndrome (AIDS) is caused by HIV (human immunodeficiency virus), which both attacks and escapes the immune system.
It infects helper T cells with high efficiency.
It escapes the immune system through its high mutation rate, which reduces the ability of the immune system to eliminate the infection.
It also can undergo latency.
People with AIDS are highly susceptible to infections and cancers that a healthy immune system would normally defeat.
Unprotected sex and transmission via HIV-contaminated needles account for the majority of HIV infections.
HIV cannot be cured, but drugs have been developed to slow HIV replication and progression to AIDS.
Cancer and Immunity
The frequency of certain cancers increases when adaptive immunity is impaired.
15–20% of all human cancers involve viruses.
The immune system can act as a defense against viruses that cause cancer and against cancer cells that harbor viruses.
In 2006, a vaccine was released that acts against human papillomavirus (HPV), a virus associated with cervical cancer.